Get started
Author

Terasa Bulger

Observed names: T. Bulger, T. F. Bulger, Terasa F. Bulger
ORCID: 0009-0007-7802-4095
Observed ORCID: 0009-0007-7802-4095
OpenAlex ID: A5082705613
Malignant hyperthermia: a review
2015 · Henry Rosenberg, Neil Pollock, et al. · Orphanet Journal of Rare Diseases · 636
PDF
Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
2020 · Henrik Rüffert, Börge Bastian, et al. · British Journal of Anaesthesia · 108
Functional analysis ofRYR1variants linked to malignant hyperthermia
2016 · Jeremy Stephens, Anja H. Schiemann, et al. · Temperature · 24
PDF
European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility
2026 · Henrik Rüffert, Robyn Gillies, et al. · British Journal of Anaesthesia · 18
PDF
Safe Duration of Postoperative Monitoring for Malignant Hyperthermia Patients Administered Non-Triggering Anaesthesia: An Update
2015 · C. Barnes, K. M. Stowell, et al. · Anaesthesia and Intensive Care · 18
PDF
Preparation of Datex-Ohmeda Aestiva® and Aisys® anaesthetic machines for use in malignant hyperthermia susceptible patients
2012 · C. Jones, K. Bennett, et al. · Anaesthesia and Intensive Care · 17
Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia
2022 · Ruth White, Anja H. Schiemann, et al. · British Journal of Anaesthesia · 16
PDF
Safety of Exposure of Malignant Hyperthermia Non-Susceptible Patients and Their Relatives to Anaesthetic Triggering Agents
2011 · N. Pollock, E. E. Langton, et al. · Anaesthesia and Intensive Care · 13
Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia
2017 · Remai Parker, Anja H. Schiemann, et al. · Journal of Neuromuscular Diseases · 9
PDF
Functional Characterization of 2 Known Ryanodine Receptor Mutations Causing Malignant Hyperthermia
2013 · Anja H. Schiemann, Neeti Paul, et al. · Anesthesia & Analgesia · 9
RYR1 variant c.38T>G, p.Leu13Arg causes hypersensitivity of the ryanodine receptor-1 and is pathogenic for malignant hyperthermia
2021 · L.R. van den Bersselaar, T. Greven, et al. · British Journal of Anaesthesia · 7
Administration of Anaesthetic Triggering Agents to Patients Tested Malignant Hyperthermia Normal and Their Relatives in New Zealand: An Update
2017 · D. Frei, K. M. Stowell, et al. · Anaesthesia and Intensive Care · 6
PDF
A genetic mystery in malignant hyperthermia ‘solved’?
2018 · A.H. Schiemann, A.R. Bjorksten, et al. · British Journal of Anaesthesia · 4
Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia
2020 · Anja H. Schiemann, Cornelia Roesl, et al. · Journal of Neuromuscular Diseases · 3
Evidence of Malignant Hyperthermia in Patients Administered Triggering Agents before Malignant Hyperthermia Susceptibility Identified: Missed Opportunities Prior to Diagnosis
2017 · T. Y. Chan, T. F. Bulger, et al. · Anaesthesia and Intensive Care · 3
Masseter muscle rigidity and the role of DNA analysis to confirm malignant hyperthermia susceptibility
2019 · Kate Hudig, Neil Pollock, et al. · Anaesthesia and Intensive Care · 1
PDF
Corrigendum to ‘Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia’ (Br J Anaesth 2026; 136: 323–32)
2026 · Anja H. Schiemann, Sophie M. Burling, et al. · British Journal of Anaesthesia
Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia
2025 · Anja H. Schiemann, Sophie M. Burling, et al. · British Journal of Anaesthesia
PDF
Anaesthetic emergencies
2021 · Andrew Kane, Richard Armstrong, et al. · Oxford University Press eBooks
Works count: 21
Citation count: 892
H-index: 9
I10-index: 8
Year
Topic
Type